House of Commons harassment: Leadsom must pause introduction of “flawed” new policy, FDA warns
The House of Commons Committee on Standards has released its report on the new proposals for a bullying and harassment policy in Parliament.
Commenting on the recommendation that would see MPs debate in the House the most serious sanctions handed to MPs accused of bullying and harassment, FDA Assistant General Secretary Amy Leversidge said:
“In no other environment would an employee's complaint of bullying or indeed sexual harassment be subject to the scrutiny and debate of 650 individuals. Even if not named, there is every chance that circumstances published around the complaint could lead to an individual being identified.
“There is currently no impediment, other than the pleading of the Speaker, to avoid any MP in this position from naming the individual who complained. How can this build confidence for an individual to raise the most serious allegations against an MP, knowing that this very person has the power to name them in public? This is in itself bullying and intimidating behaviour.
“At the point in the proposed process when an MP is to be sanctioned for their behaviour, there is nothing to stop that MP using their parliamentary privilege to undermine the judgement of the independent investigator and plead their case directly to MPs in the House. We are back to the fundamental problem - MPs cannot be trusted to mark their own homework.
“The FDA is urging Andrea Leadsom to pause the introduction of the new policy so these fundamental details can be worked out. It is unfair to the first users of the policy to force them to navigate their way through this flawed procedure. As we have seen with the failed Respect Policy - a flawed policy quickly becomes an unusable one.”
Notes for editors
The FDA is the union for senior managers and professionals in public service, representing more than 18,000 members at grades HEO and above. Membership includes senior civil servants, government policy advisors, prosecutors, diplomats, tax professionals, economists, solicitors and other professionals working across the Government and the NHS.
The FDA (formerly the First Division Association) should be referred to simply as "The FDA" and can be described as "the senior public servants' union".
For more information contact FDA Communications Officer Tommy Newell on 020 7401 5588 or 07738 729 145.
Latest News from
Scottish Government doesn’t truly value the work of FDA members13/12/2018 13:33:00
FDA National Officer Allan Sampson yesterday responded to the announcement of the Scottish Government’s public sector pay policy.
Standards Committee response: FDA raises concerns MPs may "kick Dame Laura's recommendations into the long grass"11/12/2018 13:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons Committee on Standards initial proposals following the Dame Laura Cox report.
Depression, breakdowns and departments under pressure: the FDA finds the real impact of unsustainable workloads in the civil service07/12/2018 16:10:00
Excessive working hours culture is decreasing public sector productivity and negatively impacting the health and wellbeing of civil servants, an FDA study has found.
New harassment inquiry must not delay implementation of Dame Laura Cox’s recommendations, says FDA07/12/2018 10:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the announcement that Gemma White QC has been appointed to conduct an independent inquiry into the bullying and harassment of MPs’ parliamentary staff.
New harassment inquiry must not delay implementation of Dame Laura Cox’s recommendations, says FDA06/11/2018 16:25:00
FDA Assistant General Secretary Amy Leversidge responded to the announcement that Gemma White QC has been appointed to conduct an independent inquiry into the bullying and harassment of MPs’ parliamentary staff
FDA welcomes important, if overdue, House of Commons Commission decision26/10/2018 15:15:00
The FDA welcome the House of Commons Commission’s important, if overdue, decision to implement reform off the back of Dame Laura Cox’s inquiry into bullying and harassment in the House of Commons.
FDA welcome House of Commons Commission's "important, if overdue" decision25/10/2018 14:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons Commission’s decision to implement Dame Laura Cox’s recommendations in full.
House of Commons must not water down recommendations of harassment inquiry, FDA warns24/10/2018 13:10:00
On 24 October 2018, the House of Commons Commission will meet to consider the Dame Laura Cox inquiry into systemic bullying, harassment and sexual harassment.